Oppenheimer & Co’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $746K | Buy |
246,064
+59,500
| +32% | +$180K | 0.01% | 984 |
|
|
2025
Q1 | $795K | Sell |
186,564
-14,862
| -7% | -$63.3K | 0.01% | 899 |
|
|
2024
Q4 | $1.06M | Buy |
201,426
+22,301
| +12% | +$118K | 0.02% | 755 |
|
|
2024
Q3 | $328K | Buy |
179,125
+51,944
| +41% | +$95.1K | 0.01% | 1190 |
|
|
2024
Q2 | $265K | Buy |
127,181
+117,181
| +1,172% | +$244K | ﹤0.01% | 1240 |
|
|
2024
Q1 | $40.1K | Buy |
+10,000
| New | +$40.1K | ﹤0.01% | 1418 |
|